Author:
Wang Yan,Yao Ninghua,Sun Jie
Reference40 articles.
1. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
2. Ubiquitin-specific peptidase 46 promotes tumor metastasis through stabilizing ENO1 in human esophageal squamous cell carcinoma;Tian;Exp. Cell Res.,2020
3. Epithelial cells activate fibroblasts to promote esophageal cancer development;Chen;Cancer Cell,2023
4. [Smoking tobacco and cancer risk];Scherubl;Dtsch. Med. Wochenschr.,2021
5. Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs;Chen;Cancer Lett.,2021